<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for https://www.physiciansweekly.com/feed/</title><link>https://www.physiciansweekly.com/feed/</link><description>Individual feed output.</description><lastBuildDate>Wed, 16 Jul 2025 17:23:56 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>Tardive Dyskinesia in Focus</title><link>https://www.physiciansweekly.com/tardive-dyskinesia-in-focus/</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture5.png</image_url><description>In this slideshow, we explore ICD-TD diagnosis rates, metabolites among patients with tardive dyskinesia, and more. The post Tardive Dyskinesia in Foc...</description><pubDate>Wed, 16 Jul 2025 21:19:53 GMT</pubDate></item><item><title>Clinical Trial Referral Habits: A Deeper Look at What Your Peers Are Doing in Oncology</title><link>https://www.physiciansweekly.com/clinical-trial-referral-habits-a-deeper-look-at-what-your-peers-are-doing-in-oncology/</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture2.png</image_url><description>A Physicianâ€™s Weekly survey of oncologists recently found that while most discuss clinical trial options in 11-50% of patient visits, major barriers t...</description><pubDate>Wed, 16 Jul 2025 19:58:45 GMT</pubDate></item><item><title>RISE-IBD Offers Insight Into Patient Coping Skills</title><link>https://www.physiciansweekly.com/rise-ibd-offers-insight-into-patient-coping-skills/</link><image_url>https://cdn.physiciansweekly.com/wp-content/uploads/2025/07/RISE-IBD-Graphic.jpg</image_url><description>The novel Resilience Scale for IBD, or RISE-IBD, aims to provide clinicians and patients with a tool for assessing resilience in inflammatory bowel di...</description><pubDate>Wed, 16 Jul 2025 18:59:44 GMT</pubDate></item><item><title>VICTORION-INCEPTION Trial Reframes Lipid-Lowering Strategy in Difficult-to-Treat Patients</title><link>https://www.physiciansweekly.com/victorion-trial-reframes-lipid-lowering-strategy-in-difficult-to-treat-patients/</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture6.png</image_url><description>Rachel H. Giles, PhD, and Kirk Knowlton, MD, discuss the results from the VictORIAN Inception Trial presented at the National Lipid Association. The p...</description><pubDate>Wed, 16 Jul 2025 15:23:58 GMT</pubDate></item><item><title>Addressing Gait Deficits in Multiple Sclerosis With Neuromodulation &amp; Neuroplasticity</title><link>https://www.physiciansweekly.com/addressing-gait-deficits-in-multiple-sclerosis-with-neuromodulation-neuroplasticity/</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture10.png</image_url><description>Antonella Favit-Van Pelt, MD, PhD, discusses the use of neuromodulation and neuroplasticity for addressing gait deficits in patients with multiple scl...</description><pubDate>Wed, 16 Jul 2025 15:21:03 GMT</pubDate></item></channel></rss>